首页 | 本学科首页   官方微博 | 高级检索  
检索        

趋化因子CXCL10临床研究现状
引用本文:李守杰.趋化因子CXCL10临床研究现状[J].医学综述,2010,16(12).
作者姓名:李守杰
作者单位:泰山医学院研究生部,山东泰安,271000
摘    要:CXC趋化因子配体10(CXCL10)属于CXC趋化因子超家族的非ELR类,参与多种自身免疫性疾病。它不仅可以趋化白细胞向炎症部位聚集,而且可以减少肿瘤组织的血液供应,抑制肿瘤生长;同时CXCL10及其受体CXCR3在肝脏炎症、甲状腺滤泡上皮细胞及浸润的炎性细胞中表达均显著增高。现着重对趋化因子CXCL10及其受体的结构、生物学功能及与疾病的关系予以综述。

关 键 词:CXC趋化因子配体10  疾病  免疫功能

Current Research of CXC Chemokine Ligand-10
Abstract:CXC chemokine ligand-10 belongs to the family of non-ELR-CXC chemokine,which participates in many autoimmune diseases.It can not only recruit specific subtypes of leukocytes to inflammation sites,but also reduce the blood supply to tumors and inhibit the growth of tumor.Meanwhile,CXCL10 and its receptor CXCR3 are significantly increased in liver inflammation,thyroid follicular epithelial cells and infiltration of inflammatory cells.This article reviewed the structure,biological function and the relationship of CXC chemokine ligand-10 and its receptor with multiple diseases.
Keywords:CXC chemokine ligand-10  Disease  Immune function
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号